Lieberman/Hatch Bill Offers Incentives For Countermeasure Development

Diagnostics companies conducting bioterrorism countermeasure research are given a choice of four types of tax incentives for capital formulation under the "Biological, Chemical & Radiological Weapons Countermeasures Research Act" of 2003